Eversept Global Healthcare Offshore Fund, Ltd., a Cayman Islands-based hedge fund, has filed an amendment to its Form D following $123.65M in capital raised since first sale in December 2016. The fund operates under Regulation D exemption 3(c)(7) for institutional and qualified-purchaser investors with a $100K minimum.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Sold rose from $110.2M to $123.6M (+$13.4M, +25 investors) in 365 days since the previous filing.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2024-10-15 | D/A | $86.7M | 78 | |
| 2025-10-15 | D/A | $110.2M | 115 | +$23.5M |
| 2026-10-15 | D/A | $123.6M | 140 | +$13.4M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor. All Eversept Global vehicles →
Sold rose to $NaN (+$23.5M, +37 investors) in 365 days since the previous filing.
Sold rose to $NaN (+$82.1M, +28 investors) in 365 days since the previous filing.
Sold rose to $NaN (+$126.7M, +57 investors) in 365 days since the previous filing.
Website and main-office phone from Form ADV. Subscribe to unlock
Schedule D for this adviser has not been read yet; it is queued.
12 other filings on EDGAR under this adviser, with size, strategy and date. Subscribe to unlock
| - Eversept Partners, LP | Promoter |
| Kamran Moghtaderi | Director |
| Richard Ruffer | Director |
| Scott P. Lennon | Director |
Signed by Kamran Moghtaderi, Director.
Placement agents / sales compensation: -; -; -
The issuer's phone number and address from the filing are shown to subscribers. See plans.
